Hyaluron Contract Manufacturing (HCM) Announces Patent Approval

Tag : low viscosity
Hyaluron Contract Manufacturing (HCM) Announces Patent Approval
BURLINGTON, Mass., June 24 /PRNewswire/ -- Hyaluron, Inc. dba Hyaluron Contract Manufacturing (HCM) ispleased to announce the grant of a patent and the registration of atrademark for its proprietary process for aseptic online vacuumfilling and online vacuum stoppering of low viscosity liquids insyringes. BUBBLE-FREE FILLING(R) enhances product stability foroxygen sensitive compounds where dissolved oxygen negativelyimpacts solution stability. BUBBLE-FREE FILLING(R) also providesadditional assurances of sterility by reducing stopper movement aswell as creating an unfavorable environment for the growth ofaerobic micro-organisms.
HCM was able to develop the BUBBLE-FREE FILLING(R) method byre-engineering standard syringe filling equipment and creating aunique fluid handling and transfer process. HCM has another patentpending for a proprietary aseptic processing method fornon-destructive testing of container/closure integrity. HCM iscontinually striving to improve the safety and effectiveness ofdrug delivery through its innovative processes.
About Hyaluron Contract Manufacturing
Hyaluron Contract Manufacturing aseptically fills liquid andlyophilized products into syringes, vials, and custom containers.In addition to traditional formulations, HCM excels in processdevelopment scale up of difficult formulations including:emulsions; viscous gels; suspensions, liposomes, and proteins. Foradditional information please visit: http://www.hyaluron.com and http://www.bubblefreefilling.com .
SOURCE Hyaluron Contract Manufacturing